Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Conformational Control of the Binding of the Transactivation Domain of the MLL Protein and c-Myb to the KIX Domain of CREB
  2. Korkmaz, E. N.; Nussinov, R.; Haliloglu, Y.
  3. Plos Computational Biology. 2012, Mar; 8(3):
  1. 2.   Structure of the Taz2 domain of p300: insights into ligand binding
  2. Miller, M.; Dauter, Z.; Cherry, S.; Tropea, J. E.; Wlodawer, A.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Dec; 65(Pt 12): 1301-8.
  1. 3.   Two Distinct Motifs within the p53 Transactivation Domain Bind to the Taz2 Domain of p300 and Are Differentially Affected by Phosphorylation
  2. Jenkins, L.; Yamaguchi, H.; Hayashi, R.; Cherry, S.; Tropea, J. E.; Miller, M.; Wlodawer, A.; Appella, E.; Mazur, S. J.
  3. Biochemistry. 2009 48(6): 1244-1255.
  1. 4.   Human T-cell leukemia virus type 1 tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes
  2. Wencker, M.; Sausse, C.; Derse, D.; Gazzolo, L.; Dodon, M. D.
  3. Journal of Virology. 2007, Jan; 81(1): 301-308.
  1. 5.   Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population
  2. Orloff, M. S.; Iyengar, S. K.; Winkler, C. A.; Goddard, K. A. B.; Dart, R. A.; Ahuja, T. S.; Mokrzycki, M.; Briggs, W. A.; Korbet, S. M.; Kimmel, P. L.; Simon, E. E.; Trachtman, H.; Vlahov, D.; Michel, D. M.; Berns, J. S.; Smith, M. C.; Schelling, J. R.; Sedor, J. R.; Kopp, J. B.
  3. Physiological Genomics. 2005, APR 14; 21(2): 212-221.
  1. 6.   Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappa B activation and transformation in resistant JB6 cells
  2. Hu, J.; Nakano, H.; Sakurai, H.; Colburn, N. H.
  3. Carcinogenesis. 2004, OCT; 25(10): 1991-2003.
  1. 7.   Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex
  2. Kino, T.; Slobodskaya, O.; Pavlakis, G. N.; Chrousos, G. P.
  3. Journal of Biological Chemistry. 2002 277(4): 2396-2405.
  1. 8.   Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBP beta) - Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBP beta
  2. Guo, S. D.; Cichy, S. B.; He, X. W.; Yang, Q. Y.; Ragl, M.; Ghosh, A. K.; Johnson, P. F.; Unterman, T. G.
  3. Journal of Biological Chemistry. 2001 276(11): 8516-8523.
  1. 9.   Acetyltransferases and tumour suppression
  2. Phillips, A. C.; Vousden, K. H.
  3. Breast Cancer Research. 2000 2(4): 244-246.
  1. 10.   Human papillomavirus and cancer: The viral transforming genes
  2. Phillips, A. C.; Vousden, K. H.; Newton, R.; Beral, V.; Weiss, R. A.
  3. Infections and Human Cancer. 1999; 33 : 55-74.
  1. 11.   The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor
  2. Kino, T.; Gragerov, A.; Kopp, J. B.; Stauber, R. H.; Pavlakis, G. N.; Chrousos, G. P.
  3. Journal of Experimental Medicine. 1999 189(1): 51-61.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel